Prognostic value of epidermal growth factor receptor mutations in resected non-small cell lung cancer: a systematic review with meta-analysis.

Prognostic value of epidermal growth factor receptor mutations in resected non-small cell lung cancer: a systematic review with meta-analysis.

The prognostic value of epidermal growth factor receptor (EGFR) mutations in resected non-small cell lung cancer (NSCLC) remains controversial. We performed a systematic review with meta-analysis to assess its role.Studies were identified via an electronic search on PubMed, Embase and Cochrane Libra...

Full description

Bibliographic Details
Main Authors:	Zhixuan Zhang, Ting Wang, Jun Zhang, Xiaohong Cai, Changchuan Pan, Yu Long, Jing Chen, Chengya Zhou, Xude Yin
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4146589?pdf=render

Similar Items

Epidermal Growth Factor Receptor Mutations and Their Prognostic Value with Carcinoembryonic Antigen in Pathological T1 Lung Adenocarcinoma
by: Wang-Yu Zhu, et al.
Published: (2018-01-01)

The Prognostic and Predictive Role of Epidermal Growth Factor Receptor in Surgical Resected Pancreatic Cancer
by: Meng Guo, et al.
Published: (2016-07-01)

Extent of Visceral Pleural Invasion Affects Prognosis of Resected Non-small Cell Lung Cancer: A meta-analysis
by: Ting Wang, et al.
Published: (2017-05-01)

Prognostic value of localization of epidermal growth factor receptor in lung adenocarcinoma
by: Jinn-Li Wang, et al.
Published: (2018-06-01)

Dual-energy spectral CT characteristics in surgically resected lung adenocarcinoma: comparison between Kirsten rat sarcoma viral oncogene mutations and epidermal growth factor receptor mutations
by: Meng Li, et al.
Published: (2019-11-01)

Adenocarcinoma of the lung with positive epidermal growth factor receptor mutation in pregnancy
by: Gina Amanda, et al.
Published: (2017-01-01)

Prognostic significance of Human epidermal growth factor receptor-2 expression in patients with resectable gastric adenocarcinoma
by: Hyeongbin Kim, et al.
Published: (2019-07-01)

The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer
by: Shih-Chieh Chang, et al.
Published: (2011-06-01)

Prognostic value of EGFR and KRAS in resected non-small cell lung cancer: a systematic review and meta-analysis
by: Zhang SM, et al.
Published: (2018-09-01)

Mutations in the exons of epidermal growth factor receptor gene are associated with clinicopathological features of lung cancer
by: Yanhui Wan, et al.
Published: (2020-10-01)

Epidermal growth factor receptor and KRAS mutations in Brazilian lung cancer patients
by: Carlos E. Bacchi, et al.
Published: (2012-01-01)

Histologic Grade Is Predictive of Incidence of Epidermal Growth Factor Receptor Mutations in Metastatic Lung Adenocarcinoma
by: Michelle Levy, et al.
Published: (2017-12-01)

Prognostic Value of Pleural Lavage Cytology in Patients with Lung Cancer Resection: An Updated Meta-Analysis.
by: Chun-Mei Wang, et al.
Published: (2016-01-01)

Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data
by: S.E.D.C. Jorge, et al.
Published: (2014-11-01)

Epidermal Growth Factor Receptor Mutations and Radiotherapy  in Non-small Cell Lung Cancer
by: Xing ZHONG, et al.
Published: (2013-03-01)

Epidermal growth factor receptor mutations in nonsmall cell lung carcinoma patients in Kuwait
by: Rabeah Al-Temaimi, et al.
Published: (2016-01-01)

Protein expression, gene amplification, epidermal growth factor receptor mutations and lung carcinoma
by: Panjković Milana, et al.
Published: (2014-01-01)

Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma
by: Sonobe, Makoto
Published: (2011)

Diagnostic value of mutation-specific antibodies for immunohistochemical detection of epidermal growth factor receptor mutations in non-small cell lung cancer: a meta-analysis.
by: Zi Chen, et al.
Published: (2014-01-01)

Quantitative Biomarkers for Prediction of Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Cancer
by: Liwen Zhang, et al.
Published: (2018-02-01)

Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types
by: Sojung Park, et al.
Published: (2021-01-01)

Discordance of epidermal growth factor receptor mutation between primary lung tumor and paired distant metastases in non-small cell lung cancer: A systematic review and meta-analysis.
by: Chia Ching Lee, et al.
Published: (2019-01-01)

Reliability of using circulating tumor cells for detecting epidermal growth factor receptor mutation status in advanced non-small-cell lung cancer patients: a meta-analysis and systematic review
by: Hu F, et al.
Published: (2018-03-01)

Prognostic Impact of Epidermal Growth Factor Receptor Overexpression in Patients with Cervical Cancer: A Meta-Analysis.
by: Wei-Jie Tian, et al.
Published: (2016-01-01)

Study of the association between WWOX polymorphism in lung cancer with epidermal growth factor receptor mutation
by: Chih-Yun Lin, et al.
Published: (2018)

Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging Therapies
by: Karam Khaddour, et al.
Published: (2021-06-01)

The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation
by: Shang-Gin Wu, et al.
Published: (2020-08-01)

Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
by: Connor O’Leary, et al.
Published: (2020-09-01)

Epidermal growth factor receptor mutation in lung adenocarcinoma in India: A single center study
by: Dinesh Chandra Doval, et al.
Published: (2013-01-01)

Erratum: Epidermal growth factor receptor mutations in nonsmall cell lung carcinoma patients in Kuwait
Published: (2016-01-01)

Epidermal Growth Factor Receptor Mutation Enhances Expression of Cadherin-5 in Lung Cancer Cells.
by: Ming-Szu Hung, et al.
Published: (2016-01-01)

Detection of Mutations in Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer Patients
by: Ji Ci Jhou, et al.
Published: (2009)

Prognostic value of epidermal growth factor receptor expression in operable non-small cell lung carcinoma
by: Seyhan Ekrem, et al.
Published: (2010-10-01)

Prognostic significance of epidermal growth factor receptor in surgically treated squamous cell lung cancer patients.
by: Anna Gasińska, et al.
Published: (2004-07-01)

Establishment of a Novel Method for Screening Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance Mutations in Lung Cancer
by: Hong-Xia Tian, et al.
Published: (2017-01-01)

Clinical outcomes of epidermal growth factor receptor tyrosine kinase inhibitors in recurrent adenosquamous carcinoma of the lung after resection
by: Fan L, et al.
Published: (2017-01-01)

Evaluating the Prognostic Value of ERCC1 and Thymidylate Synthase Expression and the Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma Non-Small-Cell Lung Cancer
by: Chang-Sheng Lin, et al.
Published: (2018)

Radiological and Clinical Features associated with Epidermal Growth Factor Receptor Mutation Status of Exon 19 and 21 in Lung Adenocarcinoma
by: Zhang Shi, et al.
Published: (2017-03-01)

Prognostic implication of EGFR gene mutations and histological classification in patients with resected stage I lung adenocarcinoma.
by: Chun-Yu Lin, et al.
Published: (2017-01-01)

The prognostic implications of EGFR mutation and ALK rearrangement for the long‐term outcomes of patients with resected lung adenocarcinomas
by: Hyungjin Kim, et al.
Published: (2019-07-01)